We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

LGC Clinical Diagnostics

LGC Clinical Diagnostics is a leading provider of Quality Measurement Tools, biological materials, and reagents for t... read more Featured Products: More products

Download Mobile App





Technopath Presents Comprehensive Portfolio of Diagnostic Quality Solutions at AACC 2022

By LabMedica International staff writers
Posted on 26 Jul 2022

Technopath Clinical Diagnostics (Tipperary, Ireland) will be exhibiting at the annual AACC in Chicago, IL, July 25-28 as part of the LGC Clinical Diagnostics Group which represents the combined brands: Maine Standards, SeraCare, Technopath Clinical Diagnostics, and The Native Antigen Company. More...

Technopath will present a comprehensive portfolio of catalogue and custom-developed diagnostic quality solutions and component materials at AACC 2022.

Technopath is showcasing the Multichem range of barcoded consolidated Quality Control (QC) materials combined with IAMQC informatics software that offer unique work-flow automation. By utilizing Multichem barcoded QC materials, laboratories can optimize their QC workflow and minimize handling errors. The company’s newest barcoded QC products can be recognized by the instrument, QC targets automatically downloaded to the instrument, and QC data automatically collected and reported in real-time. Technopath is also highlighting its Multichem range of independent consolidated QC materials. With an extensive list of analytes included in the Multichem range of quality control products, choice and flexibility are guaranteed for all customers. The company’s third-party quality control products include general clinical chemistry, immunoproteins, immunoassay, cardiac, urine chemistry, infectious disease, diabetes and other esoteric controls.

In addition, Technopath will demonstrate the IAMQC Infinity open QC data management solution that can complement and support the Multichem QC product range, and provides laboratory managers and technologists with a range of QC software tools to analyze their QC results in real-time. IAMQC Infinity is practical, graphical, user-definable and easy to use and provides laboratories with a centralized standardized approach to QC data management. Technopath’s IAMQC range of software products includes IAMQC Peer, an innovative, real-time, peer comparison software; IAMQC Transfer, a connectivity device (available as a virtual or physical device) that can communicate with Laboratory Information Systems (LIS), middleware, and to automated instrumentation and point of care platforms; and IAMQC Proficiency testing, a cloud-based portal used for automated submission of PT data and full PT scheme management for PT providers.
 

Related Links:
Technopath Clinical Diagnostics 


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Serological Pipet Controller
PIPETBOY GENIUS
New
Myocardial Infarction Test
Finecare cTn I/NT-proBNP Rapid Quantitative Test
New
STI Test
REALQUALITY RQ-SevenSTI
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.